The increased expression of survivin appears to be associated with the grade of metastasis and aggressiveness, reduced survival, and an increased risk of resistance to therapy in many tumor types [23,84,85], suggesting a role as an unfavorable prognostic marker [86]. The gene discussed is BIRC5; the disease is neoplasm.